Cargando…

Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.

INTRODUCTION: Autism spectrum disorder is a heterogeneous group of disorders that affects virtually every population, regardless of their ethnic or socioeconomic origin. In recent years, the attention of researchers has been drawn to the participation of the oxytocinergic and vasopressinergic system...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilczyński, K. M., Auguściak-Duma, A., Stasik, A., Cichoń, L., Sieroń, A., Janas-Kozik, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595980/
http://dx.doi.org/10.1192/j.eurpsy.2023.283
_version_ 1785124996385865728
author Wilczyński, K. M.
Auguściak-Duma, A.
Stasik, A.
Cichoń, L.
Sieroń, A.
Janas-Kozik, M.
author_facet Wilczyński, K. M.
Auguściak-Duma, A.
Stasik, A.
Cichoń, L.
Sieroń, A.
Janas-Kozik, M.
author_sort Wilczyński, K. M.
collection PubMed
description INTRODUCTION: Autism spectrum disorder is a heterogeneous group of disorders that affects virtually every population, regardless of their ethnic or socioeconomic origin. In recent years, the attention of researchers has been drawn to the participation of the oxytocinergic and vasopressinergic systems in the development of autism spectrum disorders. A relatively large number of studies have investigated the association of SNPs in these genes with the development of ASD, however, there is a lack of studies in the literature focusing on their actual effect on expression and on the effect of their expression on the risk of ASD. OBJECTIVES: The aim of this study was to assess the levels of expression of OXTR and AVPR1a genes and evaluate their links with both risk of ASD and genotypes of the most studied polymorphisms. METHODS: The study included 132 people, 77.5% of whom were male (n = 100). 113 participants (85.6%) were diagnosed with autism spectrum disorders confirmed by the ADOS-2 test conducted by a certified diagnostician. In this group, men constituted 76.1% of the population (n = 77). The remaining 28 people did not have a diagnosis of autism spectrum disorders, and in the ADOS-2 study they obtained the result below the cut-off level. The mean age in the whole group was 14.4 years (95% CI: 13.92-14.93). RESULTS: Significant decrease in expression of the OXTR gene was found in case of rs53576 where presence of the alternative allele (G) was linked to the 20% decrease in expression (2^(-ΔΔCt) = 0.8). In case of AVPR1a alternative allele (T) of SNP rs10877969 was linked to the 20% increase in the gene expression(2^(-ΔΔCt) = 1.197). SNPs rs2254298 (2^(-ΔΔCt) = 0.97) and rs7294536 (2^(-ΔΔCt) = 0.97) did not influence expression of the appropriate genes in significant way. In comparison between the test and control group in participants with confirmed diagnosis of ASD 13% lower expression of AVPR1a was found (2^(-ΔΔCt) = 0.87). CONCLUSIONS: Genotype of SNPs rs53576 and rs10877969 significantly influenced the levels of expression of the genes OXTR and AVPR1a respectively. In case of rs2254298 and rs7294536 observed effects were negligible. Presence of ASD diagnosis was linked to the 13% lower expression of AVPR1a. Abnormalities in AVPR1a expression seem to be more important for the development of autistic traits than the more attention-grabbing gene abnormalities for the oxytocinergic system. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10595980
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105959802023-10-25 Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD. Wilczyński, K. M. Auguściak-Duma, A. Stasik, A. Cichoń, L. Sieroń, A. Janas-Kozik, M. Eur Psychiatry Abstract INTRODUCTION: Autism spectrum disorder is a heterogeneous group of disorders that affects virtually every population, regardless of their ethnic or socioeconomic origin. In recent years, the attention of researchers has been drawn to the participation of the oxytocinergic and vasopressinergic systems in the development of autism spectrum disorders. A relatively large number of studies have investigated the association of SNPs in these genes with the development of ASD, however, there is a lack of studies in the literature focusing on their actual effect on expression and on the effect of their expression on the risk of ASD. OBJECTIVES: The aim of this study was to assess the levels of expression of OXTR and AVPR1a genes and evaluate their links with both risk of ASD and genotypes of the most studied polymorphisms. METHODS: The study included 132 people, 77.5% of whom were male (n = 100). 113 participants (85.6%) were diagnosed with autism spectrum disorders confirmed by the ADOS-2 test conducted by a certified diagnostician. In this group, men constituted 76.1% of the population (n = 77). The remaining 28 people did not have a diagnosis of autism spectrum disorders, and in the ADOS-2 study they obtained the result below the cut-off level. The mean age in the whole group was 14.4 years (95% CI: 13.92-14.93). RESULTS: Significant decrease in expression of the OXTR gene was found in case of rs53576 where presence of the alternative allele (G) was linked to the 20% decrease in expression (2^(-ΔΔCt) = 0.8). In case of AVPR1a alternative allele (T) of SNP rs10877969 was linked to the 20% increase in the gene expression(2^(-ΔΔCt) = 1.197). SNPs rs2254298 (2^(-ΔΔCt) = 0.97) and rs7294536 (2^(-ΔΔCt) = 0.97) did not influence expression of the appropriate genes in significant way. In comparison between the test and control group in participants with confirmed diagnosis of ASD 13% lower expression of AVPR1a was found (2^(-ΔΔCt) = 0.87). CONCLUSIONS: Genotype of SNPs rs53576 and rs10877969 significantly influenced the levels of expression of the genes OXTR and AVPR1a respectively. In case of rs2254298 and rs7294536 observed effects were negligible. Presence of ASD diagnosis was linked to the 13% lower expression of AVPR1a. Abnormalities in AVPR1a expression seem to be more important for the development of autistic traits than the more attention-grabbing gene abnormalities for the oxytocinergic system. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10595980/ http://dx.doi.org/10.1192/j.eurpsy.2023.283 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Wilczyński, K. M.
Auguściak-Duma, A.
Stasik, A.
Cichoń, L.
Sieroń, A.
Janas-Kozik, M.
Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.
title Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.
title_full Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.
title_fullStr Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.
title_full_unstemmed Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.
title_short Impact of selected single nucleotide polymorphisms in OXTR and AVPR1a genes on their expression in persons with ASD.
title_sort impact of selected single nucleotide polymorphisms in oxtr and avpr1a genes on their expression in persons with asd.
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595980/
http://dx.doi.org/10.1192/j.eurpsy.2023.283
work_keys_str_mv AT wilczynskikm impactofselectedsinglenucleotidepolymorphismsinoxtrandavpr1agenesontheirexpressioninpersonswithasd
AT augusciakdumaa impactofselectedsinglenucleotidepolymorphismsinoxtrandavpr1agenesontheirexpressioninpersonswithasd
AT stasika impactofselectedsinglenucleotidepolymorphismsinoxtrandavpr1agenesontheirexpressioninpersonswithasd
AT cichonl impactofselectedsinglenucleotidepolymorphismsinoxtrandavpr1agenesontheirexpressioninpersonswithasd
AT sierona impactofselectedsinglenucleotidepolymorphismsinoxtrandavpr1agenesontheirexpressioninpersonswithasd
AT janaskozikm impactofselectedsinglenucleotidepolymorphismsinoxtrandavpr1agenesontheirexpressioninpersonswithasd